Cargando…
Dilemma of prescribing aripiprazole under the Taiwan health insurance program: a descriptive study
OBJECTIVES: Refractory major depressive disorder (MDD) is a serious problem leading to a heavy economic burden. Antipsychotic augmentation treatment with aripiprazole and quetiapine is approved for MDD patients and can achieve a high remission rate. This study aimed to examine how psychiatrists in T...
Autores principales: | Hsu, Yi-Chien, Chou, Yu-Ching, Chang, Hsin-An, Kao, Yu-Chen, Huang, San-Yuan, Tzeng, Nian-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315562/ https://www.ncbi.nlm.nih.gov/pubmed/25657586 http://dx.doi.org/10.2147/NDT.S75609 |
Ejemplares similares
-
Electroconvulsive Therapy and Risk of Dementia—A Nationwide Cohort Study in Taiwan
por: Chu, Ching-Wen, et al.
Publicado: (2018) -
Association between amphetamine‐related disorders and dementia‐a nationwide cohort study in Taiwan
por: Tzeng, Nian‐Sheng, et al.
Publicado: (2020) -
Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
por: Tien, Yun, et al.
Publicado: (2022) -
Risk of Psychiatric Morbidity in Psychosexual Disorders in Male Patients: A Nationwide, Cohort Study in Taiwan
por: Tzeng, Nian-Sheng, et al.
Publicado: (2019) -
Are Anticholinergic Medications Associated With Increased Risk of Dementia and Behavioral and Psychological Symptoms of Dementia? A Nationwide 15-Year Follow-Up Cohort Study in Taiwan
por: Liu, Yia-Ping, et al.
Publicado: (2020)